Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 3 Comparison of trial pharmacists and independent pharmacist rating of MRP severity

From: Medication-related problems identified by community pharmacists: a descriptive case study of two Australian populations

Potential severity rating

IMeRSe (n = 354*)

PharMIbridge (n = 170)

 

Pharmacist rated

n (%)

Independent pharmacist rating

n (%)

Pharmacist rated

n (%)

Independent pharmacist rating

n (%)

High (S4)

99 (28.0)

2 (0.6)

15 (8.8)

2 (1.2)

Moderate (S3)

140 (39.6)

171 (48.3)

56 (32.9)

113 (66.5)

Mild (S2)

79 (22.3)

56 (15.8)

81 (47.7)

46 (27.1)

Low (S1)

27 (7.6)

102 (28.8)

15 (8.8)

2 (1.2)

Nil (S0)

9 (2.5)

23 (6.5)

3 (1.8)

7 (4.1)

Mean score (SD)

2.8 (1.0)

2.1 (1.0)

2.4 (0.8)

2.6 (0.7)

P-value#

p < 0.001

p = 0.008

  1. *Rating of MRP severity was introduced into the GuildCare NG™ module during the course of the trial (Feb 2019); data only available for Medicines Talks that took place after this date is compared (n = 354). # Paired t-test
Back to article page

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us